{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,7]],"date-time":"2026-11-07T10:31:06Z","timestamp":1794047466864,"version":"4.8.0"},"reference-count":47,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,7,9]],"date-time":"2025-07-09T00:00:00Z","timestamp":1752019200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,7,9]],"date-time":"2025-07-09T00:00:00Z","timestamp":1752019200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/501100013302","name":"King Abdullah International Medical Research Center","doi-asserted-by":"publisher","award":["RC17\/093\/R"],"award-info":[{"award-number":["RC17\/093\/R"]}],"id":[{"id":"10.13039\/501100013302","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Complement Med Ther"],"DOI":"10.1186\/s12906-025-04998-5","type":"journal-article","created":{"date-parts":[[2025,7,10]],"date-time":"2025-07-10T08:47:17Z","timestamp":1752137237000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":5,"title":["Commiphora myrrha resin extract-modulated cytochrome P-450 2C9 enzyme expression in cultured Hep G2 cells is associated with resin extract-derived metabolites binding to Pregnane X receptor"],"prefix":"10.1186","volume":"25","author":[{"given":"Amani","family":"Alsharidah","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zeyad","family":"Alehaideb","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sahar S.","family":"Alghamdi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rasha S.","family":"Suliman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Saleh","family":"Althenayyan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Feras","family":"Almourfi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bader","family":"Hazazi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aljawharah","family":"Almogren","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Abeer Al","family":"Tuwaijri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohamed","family":"Boudjelal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Afrah","family":"Alkhuriji","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sabine","family":"Matou-Nasri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,7,9]]},"reference":[{"key":"4998_CR1","doi-asserted-by":"publisher","unstructured":"Wagner H, Bauer R, Melchart D, Xiao PG, Staudinger A. Thin-Layer and High Performance Liquid Chromatography of Chinese Drugs. In Chromatographic Fingerprint Analysis of Herbal Medicines Volume III; 2015. pp. 71\u201378. https:\/\/doi.org\/10.1007\/978-3-319-06047-7","DOI":"10.1007\/978-3-319-06047-7"},{"key":"4998_CR2","doi-asserted-by":"publisher","first-page":"405","DOI":"10.1007\/s00210-022-02325-0","volume":"396","author":"GE Batiha","year":"2023","unstructured":"Batiha GE, Wasef L, Teibo JO, Shaheen HM, Zakariya AM, Akinfe OA, Teibo TKA, Al-Kuraishy HM, Al-Garbee AI, Alexiou A, Papadakis M. Commiphora myrrh: a phytochemical and Pharmacological update. Naunyn Schmiedebergs Arch Pharmacol. 2023;396:405\u201320. https:\/\/doi.org\/10.1007\/s00210-022-02325-0.","journal-title":"Naunyn Schmiedebergs Arch Pharmacol"},{"key":"4998_CR3","doi-asserted-by":"publisher","first-page":"303","DOI":"10.31838\/ijpr\/2021.13.02.069","volume":"13","author":"R Abukhader","year":"2021","unstructured":"Abukhader R, Tawaha AL. Amazing benefits of myrrh. Int J Pharm Res. 2021;13:303\u20138. https:\/\/doi.org\/10.31838\/ijpr\/2021.13.02.069.","journal-title":"Int J Pharm Res"},{"key":"4998_CR4","first-page":"1327","volume":"23","author":"NA Al-Rowais","year":"2002","unstructured":"Al-Rowais NA. Herbal medicine in the treatment of diabetes mellitus. Saudi Med J. 2002;23:1327\u201331. PMID: 12506289.","journal-title":"Saudi Med J"},{"key":"4998_CR5","doi-asserted-by":"publisher","first-page":"1045","DOI":"10.1089\/acm.2011.0266","volume":"18","author":"AR Jazieh","year":"2012","unstructured":"Jazieh AR, Al Sudairy R, Abulkhair O, Alaskar A, Al Safi F, Sheblaq N, Young S, Issa M, Tamim H. Use of complementary and alternative medicine by patients with cancer in Saudi Arabia. J Altern Complement Med. 2012;18:1045\u20139. https:\/\/doi.org\/10.1089\/acm.2011.0266.","journal-title":"J Altern Complement Med"},{"key":"4998_CR6","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1016\/j.jep.2015.10.024","volume":"176","author":"MC Huang","year":"2015","unstructured":"Huang MC, Pai FT, Lin CC, Chang CM, Chang HH, Lee YC, Sun MF, Yen HR. Characteristics of traditional Chinese medicine use in patients with rheumatoid arthritis in taiwan: A nationwide population-based study. J Ethnopharmacol. 2015;176:9\u201316. https:\/\/doi.org\/10.1016\/j.jep.2015.10.024.","journal-title":"J Ethnopharmacol"},{"key":"4998_CR7","doi-asserted-by":"publisher","first-page":"86","DOI":"10.1124\/dmd.121.000420","volume":"50","author":"Y Zhang","year":"2022","unstructured":"Zhang Y, Ip CM, Lai YS, Zuo Z. Overview of current herb\u2013drug interaction databases. Drug Metab Dispos. 2022;50:86\u201394. https:\/\/doi.org\/10.1124\/dmd.121.000420.","journal-title":"Drug Metab Dispos"},{"key":"4998_CR8","doi-asserted-by":"publisher","unstructured":"Mukherjee PK, Banerjee S, Gupta BD, Kar A. Evidence-based validation of herbal medicine: translational approach. Evidence-Based validation of herbal medicine. Elsevier; 2022. pp. 1\u201341. https:\/\/doi.org\/10.1016\/B978-0-323-85542-6.00025-1.","DOI":"10.1016\/B978-0-323-85542-6.00025-1"},{"key":"4998_CR9","doi-asserted-by":"publisher","first-page":"2211","DOI":"10.1056\/NEJMra032424","volume":"352","author":"GR Wilkinson","year":"2005","unstructured":"Wilkinson GR. Drug metabolism and variability among patients in drug response. N Engl J Med. 2005;352:2211\u201321. https:\/\/doi.org\/10.1056\/NEJMra032424.","journal-title":"N Engl J Med"},{"key":"4998_CR10","doi-asserted-by":"publisher","first-page":"301","DOI":"10.1124\/dmd.113.055236","volume":"42","author":"SJ Brantley","year":"2014","unstructured":"Brantley SJ, Argikar AA, Lin YS, Nagar S, Paine MF. Herb\u2013drug interactions: challenges and opportunities for improved predictions. Drug Metab Dispos. 2014;42:301\u201317. https:\/\/doi.org\/10.1124\/dmd.113.055236.","journal-title":"Drug Metab Dispos"},{"key":"4998_CR11","doi-asserted-by":"publisher","first-page":"649","DOI":"10.1124\/pr.55.4.2","volume":"55","author":"C Handschin","year":"2003","unstructured":"Handschin C, Meyer UA. Induction of drug metabolism: the role of nuclear receptors. Pharmacol Rev. 2003;55:649\u201373. https:\/\/doi.org\/10.1124\/pr.55.4.2.","journal-title":"Pharmacol Rev"},{"key":"4998_CR12","doi-asserted-by":"publisher","first-page":"219","DOI":"10.1179\/136485905X17434","volume":"99","author":"S Al Faraj","year":"2005","unstructured":"Al Faraj S. Antagonism of the anticoagulant effect of warfarin caused by the use of Commiphora molmol as a herbal medication: a case report. Ann Trop Med Parasitol. 2005;99:219\u201320. https:\/\/doi.org\/10.1179\/136485905X17434.","journal-title":"Ann Trop Med Parasitol"},{"key":"4998_CR13","doi-asserted-by":"publisher","first-page":"361","DOI":"10.1016\/j.jsps.2021.03.002","volume":"29","author":"Z Alehaideb","year":"2021","unstructured":"Alehaideb Z, Alatar G, Nehdi A, Albaz A, Al-Eidi H, Almutairi M, Hawsa E, Alshuail N, Matou-Nasri S. Commiphora myrrha (Nees) engl. Resin extracts induce phase-I cytochrome P450 2C8, 2C9, 2C19, and 3A4 isoenzyme expressions in human hepatocellular carcinoma (HepG2) cells. Saudi Pharm J. 2021;29:361\u20138. https:\/\/doi.org\/10.1016\/j.jsps.2021.03.002.","journal-title":"Saudi Pharm J"},{"key":"4998_CR14","doi-asserted-by":"publisher","first-page":"212","DOI":"10.2174\/187231209790218163","volume":"3","author":"MA El Gendy","year":"2009","unstructured":"El Gendy MA, El-Kadi AO. Peganum harmala L. differentially modulates cytochrome P450 gene expression in human hepatoma HepG2 cells. Drug Metab Lett. 2009;3:212\u20136. https:\/\/doi.org\/10.2174\/187231209790218163.","journal-title":"Drug Metab Lett"},{"key":"4998_CR15","doi-asserted-by":"publisher","first-page":"826","DOI":"10.3390\/molecules27030826","volume":"27","author":"ZI Alehaideb","year":"2022","unstructured":"Alehaideb ZI, Venkatraman A, Kokane M, Mohamed SA, Rameshbabu S, Suliman RS, Alghamdi SS, Al-Eidi H, Alghanem B, Abdulla MH, Matou-Nasri S. Bursatella leachii purple ink secretion concentrate exerts cytotoxic properties against human hepatocarcinoma cell line (HepG2): in vitro and in Silico studies. Molecules. 2022;27:826. https:\/\/doi.org\/10.3390\/molecules27030826.","journal-title":"Molecules"},{"key":"4998_CR16","doi-asserted-by":"publisher","first-page":"1121","DOI":"10.1007\/BF02623686","volume":"26","author":"J Epstein","year":"1990","unstructured":"Epstein J, Lee MM, Kelly CE, Donahoe PK. Effect of E. coli endotoxin on mammalian cell growth and Recombinant protein production. Vitro Cell Dev Biol. 1990;26:1121\u20132. https:\/\/doi.org\/10.1007\/BF02623686.","journal-title":"Vitro Cell Dev Biol"},{"key":"4998_CR17","doi-asserted-by":"publisher","first-page":"322","DOI":"10.1021\/mp0500824","volume":"3","author":"MS Al-Dosari","year":"2006","unstructured":"Al-Dosari MS, Knapp JE, Liu D. Activation of human CYP2C9 promoter and regulation by CAR and PXR in mouse liver. Mol Pharm. 2006;3:322\u20138. https:\/\/doi.org\/10.1021\/mp0500824.","journal-title":"Mol Pharm"},{"key":"4998_CR18","doi-asserted-by":"publisher","first-page":"231","DOI":"10.1016\/j.bcp.2013.05.008","volume":"86","author":"M Niemira","year":"2013","unstructured":"Niemira M, Dastych J, Mazerska Z. Pregnane X receptor dependent up-regulation of CYP2C9 and CYP3A4 in tumor cells by antitumor acridine agents, C-1748 and C-1305, selectively diminished under hypoxia. Biochem Pharmacol. 2013;86:231\u201341. https:\/\/doi.org\/10.1016\/j.bcp.2013.05.008.","journal-title":"Biochem Pharmacol"},{"key":"4998_CR19","doi-asserted-by":"publisher","first-page":"917","DOI":"10.1016\/0031-9422(86)80027-9","volume":"25","author":"GJ Provan","year":"1986","unstructured":"Provan GJ, Waterman PG. The mansumbinanes: Octanordammaranes from the resin of Commiphora Incisa. Phytochemistry. 1986;25:917\u201322. https:\/\/doi.org\/10.1016\/0031-9422(86)80027-9.","journal-title":"Phytochemistry"},{"key":"4998_CR20","doi-asserted-by":"publisher","first-page":"187","DOI":"10.1016\/S0031-9422(00)80085-0","volume":"22","author":"CH Brieskorn","year":"1983","unstructured":"Brieskorn CH, Noble P. Two Furanoeudesmanes from the essential oil of myrrh. Phytochemistry. 1983;22:187\u20139. https:\/\/doi.org\/10.1016\/S0031-9422(00)80085-0.","journal-title":"Phytochemistry"},{"key":"4998_CR21","doi-asserted-by":"publisher","first-page":"3037","DOI":"10.1016\/j.bmc.2004.03.020","volume":"12","author":"H Matsuda","year":"2004","unstructured":"Matsuda H, Morikawa T, Ando S, Oominami H, Murakami T, Kimura I, Yoshikawa M. Absolute stereostructures of polypodane- and octanordammarane-type triterpenes with nitric oxide production inhibitory activity from guggul-gum resins. Bioorg Med Chem. 2004;12:3037\u201346. https:\/\/doi.org\/10.1016\/j.bmc.2004.03.020.","journal-title":"Bioorg Med Chem"},{"key":"4998_CR22","doi-asserted-by":"publisher","first-page":"217","DOI":"10.1016\/S0021-9673(01)98676-5","volume":"23","author":"IC Nigam","year":"1966","unstructured":"Nigam IC, Levi L. Essential oils and their constituents: XXXII. Gas chromatography of sesquiterpene hydrocarbons. J Chromatogr A. 1966;23:217\u201326. https:\/\/doi.org\/10.1016\/S0021-9673(01)98676-5.","journal-title":"J Chromatogr A"},{"key":"4998_CR23","doi-asserted-by":"publisher","first-page":"3177","DOI":"10.1016\/0040-4039(64)83130-0","volume":"5","author":"AF Thomas","year":"1964","unstructured":"Thomas AF, Willhalm B. The triterpenes of Commiphora IV mass spectra and organic analysis V mass spectroscopic studies and the structure of commic acids A and B. Tetrahedron Lett. 1964;5:3177\u201383.","journal-title":"Tetrahedron Lett"},{"key":"4998_CR24","doi-asserted-by":"publisher","first-page":"4288","DOI":"10.2174\/1381612822666160607070736","volume":"22","author":"K Vasisht","year":"2016","unstructured":"Vasisht K, Sharma N, Karan M. Current perspective in the international trade of medicinal plants material: an update. Curr Pharm Des. 2016;22:4288\u2013336. https:\/\/doi.org\/10.2174\/1381612822666160607070736.","journal-title":"Curr Pharm Des"},{"key":"4998_CR25","doi-asserted-by":"publisher","unstructured":"Khan MSA, Ahmad I, Chattopadhyay D. New look to phytomedicine: advancements in herbal products as novel drug leads. Academic; 2019. pp. 3\u201313. https:\/\/doi.org\/10.1016\/C2017-0-01165-5.","DOI":"10.1016\/C2017-0-01165-5"},{"key":"4998_CR26","doi-asserted-by":"publisher","first-page":"651","DOI":"10.1007\/s40264-022-01180-5","volume":"45","author":"FPAM van Hunsel","year":"2022","unstructured":"van Hunsel FPAM, Kroes BH, Woerdenbag HJ. Analysis of reports on adverse drug reactions related to herbal medicinal products and herbal supplements in the Netherlands received by the National pharmacovigilance centre Lareb. Drug Saf. 2022;45:651\u201361. https:\/\/doi.org\/10.1007\/s40264-022-01180-5.","journal-title":"Drug Saf"},{"key":"4998_CR27","doi-asserted-by":"publisher","first-page":"577","DOI":"10.1007\/s40801-023-00388-w","volume":"10","author":"W Alghamdi","year":"2023","unstructured":"Alghamdi W, Al-Fadel N, Alghamdi EA, Alghamdi M, Alharbi F. Signal detection and assessment of herb-drug interactions: Saudi food and drug authority experience. Drugs Real World Outcomes. 2023;10:577\u201385. https:\/\/doi.org\/10.1007\/s40801-023-00388-w.","journal-title":"Drugs Real World Outcomes"},{"key":"4998_CR28","doi-asserted-by":"publisher","first-page":"154710","DOI":"10.1016\/j.phymed.2023.154710","volume":"112","author":"Y Xing","year":"2023","unstructured":"Xing Y, Yu Q, Zhou L, Cai W, Zhang Y, Bi Y, Zhang Y, Fu Z, Han L. Cytochrome P450-mediated herb-drug interaction (HDI) of Polygonum multiflorum thunb. Based on Pharmacokinetic studies and in vitro Inhibition assays. Phytomedicine. 2023;112:154710. https:\/\/doi.org\/10.1016\/j.phymed.2023.154710.","journal-title":"Phytomedicine"},{"key":"4998_CR29","doi-asserted-by":"publisher","first-page":"444","DOI":"10.1016\/j.jsps.2023.01.011","volume":"31","author":"Z Alehaideb","year":"2023","unstructured":"Alehaideb Z. Prediction of herb-drug interactions involving consumption of furanocoumarin-mixtures and cytochrome P450 1A2-mediated caffeine metabolism Inhibition in humans. Saudi Pharm J. 2023;31:444\u201352. https:\/\/doi.org\/10.1016\/j.jsps.2023.01.011.","journal-title":"Saudi Pharm J"},{"key":"4998_CR30","doi-asserted-by":"publisher","first-page":"12808","DOI":"10.3390\/ijms222312808","volume":"22","author":"M Zhao","year":"2021","unstructured":"Zhao M, Ma J, Li M, Zhang Y, Jiang B, Zhao X, Huai C, Shen L, Zhang N, He L, Qin S. Cytochrome P450 enzymes and drug metabolism in humans. Int J Mol Sci. 2021;22:12808. https:\/\/doi.org\/10.3390\/ijms222312808.","journal-title":"Int J Mol Sci"},{"issue":"616","key":"4998_CR31","doi-asserted-by":"publisher","first-page":"610","DOI":"10.2144\/00293rr04","volume":"29","author":"KA Butash","year":"2000","unstructured":"Butash KA, Natarajan P, Young A, Fox DK. Reexamination of the effect of endotoxin on cell proliferation and transfection efficiency. Biotechniques. 2000;29(616):610\u20134. https:\/\/doi.org\/10.2144\/00293rr04.","journal-title":"Biotechniques"},{"key":"4998_CR32","doi-asserted-by":"publisher","first-page":"2209","DOI":"10.1172\/JCI117582","volume":"94","author":"SI Shedlofsky","year":"1994","unstructured":"Shedlofsky SI, Israel BC, McClain CJ, Hill DB, Blouin RA. Endotoxin administration to humans inhibits hepatic cytochrome P450-mediated drug metabolism. J Clin Invest. 1994;94:2209\u201314. https:\/\/doi.org\/10.1172\/JCI117582.","journal-title":"J Clin Invest"},{"key":"4998_CR33","doi-asserted-by":"crossref","unstructured":"Duke JA. Handbook of medicinal herbs. CRC press 2002. Boca Raton. DOI: 12019781420040463.","DOI":"10.1201\/9781420040463"},{"key":"4998_CR34","first-page":"1","volume":"1","author":"US Food and Drug Administration","year":"2020","unstructured":"US Food and Drug Administration. In vitro drug interaction studies-cytochrome P450 enzyme and transporter mediated drug interactions. FDA Guid. 2020;1:1.","journal-title":"FDA Guid"},{"key":"4998_CR35","doi-asserted-by":"publisher","first-page":"279","DOI":"10.1080\/00498254.2020.1867929","volume":"51","author":"J Liu","year":"2021","unstructured":"Liu J, Lu YF, Corton JC, Klaassen CD. Expression of cytochrome P450 isozyme transcripts and activities in human livers. Xenobiotica. 2021;51:279\u201386. https:\/\/doi.org\/10.1080\/00498254.2020.1867929.","journal-title":"Xenobiotica"},{"key":"4998_CR36","doi-asserted-by":"publisher","first-page":"1460948","DOI":"10.3389\/fphar.2024.1460948","volume":"15","author":"SC Li","year":"2024","unstructured":"Li SC, Wang B, Zhang M, Yin Q, Yang ZY, Li XT, Liang G. Induction of cytochrome P450 via upregulation of CAR and PXR: a potential mechanism for altered flofernicol metabolism by Macranthoidin B in vivo. Front Pharmacol. 2024;15:1460948. https:\/\/doi.org\/10.3389\/fphar.2024.1460948.","journal-title":"Front Pharmacol"},{"key":"4998_CR37","doi-asserted-by":"publisher","first-page":"228","DOI":"10.1124\/dmd.122.000858","volume":"51","author":"S Poudel","year":"2023","unstructured":"Poudel S, Huber AD, Chen T. Regulation of nuclear receptors PXR and CAR by small molecules and signal crosstalk: roles in drug metabolism and beyond. Drug Metab Dispos. 2023;51:228\u201336. https:\/\/doi.org\/10.1124\/dmd.122.000858.","journal-title":"Drug Metab Dispos"},{"key":"4998_CR38","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1002\/jbt.20264","volume":"23","author":"J Sahi","year":"2009","unstructured":"Sahi J, Shord SS, Lindley C, Ferguson S, LeCluyse EL. Regulation of cytochrome P450 2C9 expression in primary cultures of human hepatocytes. J Biochem Mol Toxicol. 2009;23:43\u201358.","journal-title":"J Biochem Mol Toxicol"},{"key":"4998_CR39","first-page":"549","volume":"70","author":"FI Al-Jenoobi","year":"2015","unstructured":"Al-Jenoobi FI, Alam MA, Al-Mohizea AM, Ahad A, Raish M. Orally co-administrated oleo-gum resin of Commiphora myrrha decreases the bioavailability of cyclosporine A in rats. Pharmazie. 2015;70:549\u201352. PMID: 26380525.","journal-title":"Pharmazie"},{"key":"4998_CR40","doi-asserted-by":"publisher","first-page":"501","DOI":"10.2174\/1389450119666181022153016","volume":"20","author":"S Saikia","year":"2019","unstructured":"Saikia S, Bordoloi M. Molecular docking: challenges, advantages and its use in drug discovery perspective. Curr Drug Targets. 2019;20:501\u201321. https:\/\/doi.org\/10.2174\/1389450119666181022153016.","journal-title":"Curr Drug Targets"},{"key":"4998_CR41","doi-asserted-by":"publisher","DOI":"10.2174\/0109298673325827240926081845","author":"C Aguiar","year":"2024","unstructured":"Aguiar C, Camps I. Molecular Docking in drug discovery: techniques, applications, and advancements. Curr Med Chem. 2024. https:\/\/doi.org\/10.2174\/0109298673325827240926081845. Epub ahead of print.","journal-title":"Curr Med Chem"},{"key":"4998_CR42","doi-asserted-by":"publisher","first-page":"2927","DOI":"10.1016\/j.apsb.2024.03.002","volume":"14","author":"J Liu","year":"2024","unstructured":"Liu J, Gui Y, Rao J, Sun J, Wang G, Ren Q, Qu N, Niu B, Chen Z, Sheng X, et al. In Silico off-target profiling for enhanced drug safety assessment. Acta Pharm Sin B. 2024;14:2927\u201341. https:\/\/doi.org\/10.1016\/j.apsb.2024.03.002.","journal-title":"Acta Pharm Sin B"},{"key":"4998_CR43","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1046\/j.1365-2362.33.s2.6.x","volume":"33","author":"UI Schwarz","year":"2003","unstructured":"Schwarz UI. Clinical relevance of genetic polymorphisms in the human CYP2C9 gene. Eur J Clin Invest. 2003;33:23\u201330. https:\/\/doi.org\/10.1046\/j.1365-2362.33.s2.6.x.","journal-title":"Eur J Clin Invest"},{"key":"4998_CR44","first-page":"43","volume":"24","author":"YC Kang","year":"2015","unstructured":"Kang YC, Chen MH, Lai SL. Potentially unsafe herb-drug interactions between a commercial product of noni juice and phenytoin-a case report. Acta Neurol Taiwan. 2015;24:43\u20136. PMID: 26179835.","journal-title":"Acta Neurol Taiwan"},{"key":"4998_CR45","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1016\/S0975-3575(11)80023-4","volume":"2","author":"RH Chandra","year":"2011","unstructured":"Chandra RH, Veeresham C. Herb\u2014drug interaction of noni juice and Ginkgo biloba with phenytoin. Pharmacognosy J. 2011;2:33\u201341.","journal-title":"Pharmacognosy J"},{"key":"4998_CR46","first-page":"89","volume":"8","author":"K Santiago","year":"2010","unstructured":"Santiago K, Gaikwad A, Coffer II, Smith L. Evaluation of the hepatic metabolism and antitumor activity of noni juice (Morinda citrifolia L.) in combination with chemotherapy. J Soc Integr Oncol. 2010;8:89\u201394.","journal-title":"J Soc Integr Oncol"},{"key":"4998_CR47","first-page":"116","volume":"5","author":"RK Premchand","year":"2021","unstructured":"Premchand RK, Samnani N. Case report on interaction of warfarin with herbal medicine Kadha. IHJ Cardiovasc Case Rep (CVCR). 2021;5:116\u20138.","journal-title":"IHJ Cardiovasc Case Rep (CVCR)"}],"container-title":["BMC Complementary Medicine and Therapies"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12906-025-04998-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12906-025-04998-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12906-025-04998-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,7,10]],"date-time":"2025-07-10T08:47:19Z","timestamp":1752137239000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmccomplementalternmed.biomedcentral.com\/articles\/10.1186\/s12906-025-04998-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,7,9]]},"references-count":47,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["4998"],"URL":"https:\/\/doi.org\/10.1186\/s12906-025-04998-5","relation":{},"ISSN":["2662-7671"],"issn-type":[{"value":"2662-7671","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,7,9]]},"assertion":[{"value":"8 September 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 June 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 July 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"All authors reviewed and approved the manuscript for publication.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"247"}}